1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Colombia Pharmaceuticals and Healthcare Report Q3 2016

Colombia Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 88 pages

Includes 3 FREE quarterly updates

BMI View: Colombia's deteriorating regulatory regime will continue to limit the country's attractiveness tomultinational pharmaceutical companies in the coming years. Despite the country's growing rates ofmedicine consumption, the increasing compulsory license risks and patent regulation burdens as well assubstandard pricing controls will remain critical threats to pharmaceutical investment in the country overthe long term.

Headline Expenditure Projections

- Pharmaceuticals: COP9,101bn (USD3.31bn) in 2015 to COP9,581bn (USD3.10bn) in 2016; +5.3% inlocal currency and -6.6% in US dollars.

- Healthcare: COP59,425bn (USD21.6bn) in 2015 to COP64,692bn (USD20.9bn) in 2016; +8.9% in localcurrency and -3.4% in US dollars.

Table Of Contents

Colombia Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Colombia 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Colombia 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Colombia 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Colombia 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Colombia 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Colombia 2012-2020) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Colombia 2014-2020) 31
Table: Pharmaceutical Trade Data And Forecasts local currency (Colombia 2014-2020) 31
Pharmaceuticals Risk/Reward Index 32
Americas Risk/Reward Index 32
Colombia Risk/Reward Index 37
Rewards 37
Risks 38
Regulatory Review 39
Intellectual Property Regime 40
Table: Colombia-US FTA Mechanisms Relevant To Intellectual Property 44
Pricing Regime 44
Reimbursement Regime 46
Market Overview 49
Healthcare Sector 50
Table: Healthcare Resources (Colombia 2010-2015) 54
Table: Healthcare Personnel (Colombia 2010-2015) 54
Table: Healthcare Activity (Colombia 2010-2015) 55
Research and Development 55
Table: Pharmaceutical Research and Science Centre (CECIF) Members, 2015 55
Clinical Trials 56
Epidemiology 57
Competitive Landscape 61
Research-Based Industry 61
Table: Members Of Asociación De Laboratorios Farmaceuticos De Investigación (AFIDRO), 2012 62
Table: Multinational Market Activity 63
Table: Leading Pharmaceutical Companies By Revenues, 2011 (COPmn) 64
Pharmaceutical Distribution 65
Table: Leading Pharmaceutical Importers/Wholesalers By Revenues, 2011 66
Pharmaceutical Retail Sector 68
Company Profile 69
Laboratorios Bussie 69
Laboratorios Genfar SA 71
Lafrancol 74
Demographic Forecast 77
Table: Population Headline Indicators (Colombia 1990-2025) 78
Table: Key Population Ratios (Colombia 1990-2025) 78
Table: Urban/Rural Population and Life Expectancy (Colombia 1990-2025) 79
Table: Population By Age Group (Colombia 1990-2025) 79
Table: Population By Age Group % (Colombia 1990-2025) 80
Glossary 82
Methodology 84
Pharmaceutical Expenditure Forecast Model 84
Healthcare Expenditure Forecast Model 84
Notes On Methodology 85
Risk/Reward Index Methodology 86
Index Overview 87
Table: Pharmaceutical Risk/Reward Index Indicators 87
Indicator Weightings 88

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.